|
GART expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.765700E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.120300E-03 |
| Normal-vs-Stage2 |
3.979800E-01 |
| Normal-vs-Stage3 |
6.445200E-01 |
| Normal-vs-Stage4 |
7.832600E-01 |
| Stage1-vs-Stage2 |
5.367800E-01 |
| Stage1-vs-Stage3 |
4.352300E-02 |
| Stage1-vs-Stage4 |
1.970170E-01 |
| Stage2-vs-Stage3 |
3.522200E-01 |
| Stage2-vs-Stage4 |
4.432600E-01 |
| Stage3-vs-Stage4 |
9.540200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.553600E-02 |
| Normal-vs-AfricanAmerican |
2.227400E-01 |
| Normal-vs-Asian |
7.007400E-01 |
| Caucasian-vs-AfricanAmerican |
6.359000E-01 |
| Caucasian-vs-Asian |
2.542600E-01 |
| AfricanAmerican-vs-Asian |
3.118000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.058500E-03 |
| Normal-vs-Female |
2.445000E-01 |
| Male-vs-Female |
2.815700E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.821210E-01 |
| Normal-vs-Extreme_Weight |
4.449100E-04 |
| Normal-vs-Obese |
9.089400E-01 |
| Normal-vs-Extreme_Obese |
6.070000E-02 |
| Normal_Weight-vs-Extreme_Weight |
1.561160E-01 |
| Normal_Weight-vs-Obese |
3.293400E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.980380E-01 |
| Extreme_Weight-vs-Obese |
1.149620E-02 |
| Extreme_Weight-vs-Extreme_Obese |
5.094200E-01 |
| Obese-vs-Extreme_Obese |
9.332500E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.191600E-01 |
| Normal-vs-Age(41-60Yrs) |
1.810160E-01 |
| Normal-vs-Age(61-80Yrs) |
2.603600E-02 |
| Normal-vs-Age(81-100Yrs) |
2.447300E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.096570E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.158080E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.152390E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.552600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.153870E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.408000E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.217900E-03 |
| Normal-VS-Type2 PRCC |
3.698400E-01 |
| Normal-VS-KIRP CIMP |
2.876100E-03 |
| Normal-VS-Unclassified PRCC |
1.169600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.579360E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.75030000049148E-07 |
| Type1 PRCC-VS-Unclassified PRCC |
6.393600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
6.12749999999718E-05 |
| Type2 PRCC-VS-Unclassified PRCC |
5.579800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.80490000004185E-06 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.099300E-03 |
| Normal-vs-N1 |
1.226990E-01 |
| Normal-vs-N2 |
6.867600E-01 |
| N0-vs-N1 |
9.557800E-03 |
| N0-vs-N2 |
8.303600E-01 |
| N1-vs-N2 |
3.203600E-01 |
|
|
